We represented an investment advisory and wealth management firm located in Memphis, Tennessee, with respect to its ESOP. We advised the client regarding legal compliance of the ESOP and represented the company in the sale of the ESOP to a 3rd party purchaser.
Representation of Wealth Management Firm in Sale of ESOP
You Also May Be Interested In:
Representing Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their agreement to be acquired by funds managed by Stone Point Capital, with over $40 billion of assets under management; under the terms of the agreement, Tivity Health stockholders will receive $32.50 in cash per share, representing a total transaction value of $2.0 billion
We represented a home healthcare provider in their purchase of a company partially owned by an Employee Stock Ownership Plan (ESOP).
Lead Counsel to POINT Biopharma Inc. in its SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.